Page 82 - AN-2-2

Advanced Neurology Role of immunosuppressants in autism

100. Illiano P, Brambilla R, Parolini C, 2020, The mutual pathogenesis and treatment. Expert Rev Clin Immunol,
interplay of gut microbiota, diet and human disease. FEBS 17: 27-35.
J, 287: 833–855.
https://doi.org/10.1080/1744666x.2020.1850273
https://doi.org/10.1111/febs.15217 112. Marçais A, Marotel M, Degouve S, et al., 2017, High mTOR
101. Chung J, Kuo CJ, Crabtree GR, et al., 1992, Rapamycin- activity is a hallmark of reactive natural killer cells and
FKBP specifically blocks growth-dependent activation amplifies early signaling through activating receptors. Elife,
of and signaling by the 70 kd S6 protein kinases. Cell, 6: e26423.
69: 1227–1236.
https://doi.org/10.7554/elife.26423
https://doi.org/10.1016/0092-8674(92)90643-q
113. Marçais A, Cherfils-Vicini J, Viant C, et al., 2014, The
102. Price DJ, Grove JR, Calvo V, et al., 1992, Rapamycin- metabolic checkpoint kinase mTOR is essential for IL-15
induced inhibition of the 70-kilodalton S6 protein kinase. signaling during the development and activation of NK
Science, 257: 973–977. cells. Nat Immunol, 15: 749–757.
https://doi.org/10.1126/science.1380182 https://doi.org/10.1038/ni.2936
103. Li J, Kim SG, Blenis J, 2014, Rapamycin: One drug, many 114. Nandagopal N, Ali AK, Komal AK, et al., 2014, The critical
effects. Cell Metab, 19: 373–379. role of IL-15-PI3K-mTOR pathway in natural killer cell
effector functions. Front Immunol, 5: 187.
https://doi.org/10.1016/j.cmet.2014.01.001
https://doi.org/10.3389/fimmu.2014.00187
104. Muncy J, Butler IJ, Koenig MK, 2009, Rapamycin reduces
seizure frequency in tuberous sclerosis complex. J Child 115. Ali AK, Nandagopal N, Lee SH, 2015, IL-15-PI3K-AKT-
Neurol, 24: 477–477. mTOR: A critical pathway in the life journey of natural
killer cells. Front Immunol, 6: 355.
https://doi.org/10.1177/0883073808324535
https://doi.org/10.3389/fimmu.2015.00355
105. Sato A, Kasai S, Kobayashi T, et al., 2012, Rapamycin
reverses impaired social interaction in mouse models of 116. Mah AY, Cooper MA, 2016, Metabolic regulation of natural
tuberous sclerosis complex. Nat Commun, 3: 1292. killer cell IFN-γ production. Crit Rev Immunol, 36: 131–147.
https://doi.org/10.1038/ncomms2295 https://doi.org/10.1615/critrevimmunol.2016017387
106. Chen J, Alberts I, Li X, 2014, Dysregulation of the IGF-I/ 117. Wai LE, Fujiki M, Takeda S, et al., 2008, Rapamycin, but not
PI3K/AKT/mTOR signaling pathway in autism spectrum cyclosporine or FK506, alters natural killer cell function.
disorders. Int J Dev Neurosci, 35: 35–41. Transplantation, 85: 145–149.
https://doi.org/10.1016/j.ijdevneu.2014.03.006 https://doi.org/10.1097/01.tp.0000296817.28053.7b
107. Eden KE, de Vries PJ, Moss J, et al., 2014, Self-injury and 118. Kumar S, Mehan S, Narula AS, 2022, Therapeutic
aggression in tuberous sclerosis complex: Cross syndrome modulation of JAK-STAT, mTOR, and PPAR-γ signaling in
comparison and associated risk markers. J Neurodev neurological dysfunctions. J Mol Med, 101: 1–41.
Disord, 6: 10. https://doi.org/10.1007/s00109-022-02272-6
https://doi.org/10.1186/1866-1955-6-10
119. Dreyer C, Krey G, Keller H, et al., 1992, Control of the
108. Tsai PT, Hull C, Chu Y, et al., 2012, Autistic-like behaviour peroxisomal beta-oxidation pathway by a novel family of
and cerebellar dysfunction in Purkinje cell Tsc1 mutant nuclear hormone receptors. Cell, 68: 879–887.
mice. Nature, 488: 647–651.
https://doi.org/10.1016/0092-8674(92)90031-7
https://doi.org/10.1038/nature11310
120. Kwan V, Unda BK, Singh KK, 2016, Wnt signaling networks
109. Curatolo P, Moavero R, de Vries PJ, 2015, Neurological and in autism spectrum disorder and intellectual disability.
neuropsychiatric aspects of tuberous sclerosis complex. J Neurodev Disord, 8: 45.
Lancet Neurol, 14: 733–745.
https://doi.org/10.1186/s11689-016-9176-3
https://doi.org/10.1016/s1474-4422(15)00069-1
121. Caracci MO, Ávila ME, De Ferrari GV, 2016, Synaptic
110. Tang G, Gudsnuk K, Kuo SH, et al., 2014, Loss of mTOR- Wnt/GSK3β signaling hub in autism. Neural Plast,
dependent macroautophagy causes autistic-like synaptic 2016: 9603751.
pruning deficits. Neuron, 83: 1131–1143.
https://doi.org/10.1155/2016/9603751
https://doi.org/10.1016/j.neuron.2014.07.040
122. Wei J, Bhattacharyya S, Tourtellotte WG, et al., 2011,
111. Meimand SE, Rostam-Abadi Y, Rezaei N, 2020, Autism Fibrosis in systemic sclerosis: Emerging concepts and
spectrum disorders and natural killer cells: A review on implications for targeted therapy. Autoimmun Rev,

Volume 2 Issue 2 (2023) 22 https://doi.org/10.36922/an.391